CU CHAMBERLAIN UNIVERSITY
9 TINU
EST. 1889 College of Nursing & Health Professions
MN 553: Advanced Pharmacology
UNIT 9 QUIZ — PHARMACOECONOMICS, HERBALS, FOOD-DRUG INTERACTIONS & NUTRITION
INSTITUTION PROGRAM
Chamberlain University MSN — Family Nurse Practitioner
COURSE CODE COURSE TITLE
MN 553 Advanced Pharmacology
ACADEMIC YEAR EXAM TITLE
2025–2026 Unit 9 — Pharmacoeconomics, Herbals & Nutrition
TOTAL QUESTIONS EXAM FORMAT
50 Multiple Choice — Select the Single Best Answer
General Instructions
▸ Read each question carefully before selecting your answer.
▸ Select the single best answer for each multiple-choice item.
▸ This Unit 9 quiz covers pharmacoeconomic analysis types, Medicare Part D, herbal and supplement regulation
and safety, drug-food interactions, vitamin and mineral supplementation, omega-3 fatty acids, probiotics, and
nutritional deficiency assessment.
▸ All questions are weighted equally unless otherwise noted.
▸ Electronic devices, notes, and reference materials are prohibited during the examination.
Q MULTIPLE CHOICE QUESTIONS 50 Questions
,1. Pharmacoeconomics is best defined as:
A. The study of how drugs are priced by pharmaceutical companies
B. The analysis of the costs and consequences of any health-care-related treatment or service
C. The comparison of generic versus brand-name drug pricing
D. The calculation of insurance premiums for prescription coverage
CORRECT ANSWER:
B. The analysis of the costs and consequences of any health-care-related treatment or service
RATIONALE:
Pharmacoeconomics systematically analyzes the costs (direct, indirect, intangible) and consequences
(outcomes) of healthcare treatments. It helps decision-makers allocate limited healthcare resources efficiently.
Options A, C, and D describe narrow aspects of drug pricing but do not capture the full scope of
pharmacoeconomic analysis, which encompasses all health-care-related treatments and services.
2. The direct costs of drug therapy include:
A. Pain and suffering due to inadequate drug therapy
B. Loss of wages while undergoing drug therapy
C. The actual cost of the medication and related medical services
D. Travel expenses to obtain the medication
CORRECT ANSWER:
A. Pain and suffering due to inadequate drug therapy
RATIONALE:
According to the source material, direct costs of drug therapy include pain and suffering due to inadequate drug
therapy. These are costs directly associated with the treatment or its failure. Loss of wages (B) is an indirect cost.
The actual medication cost (C) is another direct cost, but the source specifically identifies pain and suffering
from inadequate therapy as a direct cost.
, 3. Indirect costs associated with drug therapy include:
A. Loss of wages while undergoing drug therapy
B. The cost of the medication itself
C. The cost of physician visits for monitoring
D. Hospitalization costs related to drug therapy
CORRECT ANSWER:
A. Loss of wages while undergoing drug therapy
RATIONALE:
Indirect costs represent productivity losses — income lost when a patient cannot work due to illness or
treatment. Loss of wages while undergoing drug therapy is a classic indirect cost. Options B, C, and D are direct
medical costs (actual healthcare expenditures). Understanding these distinctions is essential for comprehensive
pharmacoeconomic analysis.
4. The intangible costs of drug therapy include:
A. Hospitalization expenses
B. Inconvenience, pain, and suffering incurred with therapy
C. Laboratory monitoring costs
D. Lost productivity at work
CORRECT ANSWER:
B. Inconvenience, pain, and suffering incurred with therapy
RATIONALE:
Intangible costs are non-monetary, quality-of-life impacts — inconvenience, pain, suffering, anxiety, and
reduced quality of life associated with illness or treatment. They are difficult to quantify but critically important
in pharmacoeconomic analysis. Option A and C are direct costs. Option D is an indirect cost.
9 TINU
EST. 1889 College of Nursing & Health Professions
MN 553: Advanced Pharmacology
UNIT 9 QUIZ — PHARMACOECONOMICS, HERBALS, FOOD-DRUG INTERACTIONS & NUTRITION
INSTITUTION PROGRAM
Chamberlain University MSN — Family Nurse Practitioner
COURSE CODE COURSE TITLE
MN 553 Advanced Pharmacology
ACADEMIC YEAR EXAM TITLE
2025–2026 Unit 9 — Pharmacoeconomics, Herbals & Nutrition
TOTAL QUESTIONS EXAM FORMAT
50 Multiple Choice — Select the Single Best Answer
General Instructions
▸ Read each question carefully before selecting your answer.
▸ Select the single best answer for each multiple-choice item.
▸ This Unit 9 quiz covers pharmacoeconomic analysis types, Medicare Part D, herbal and supplement regulation
and safety, drug-food interactions, vitamin and mineral supplementation, omega-3 fatty acids, probiotics, and
nutritional deficiency assessment.
▸ All questions are weighted equally unless otherwise noted.
▸ Electronic devices, notes, and reference materials are prohibited during the examination.
Q MULTIPLE CHOICE QUESTIONS 50 Questions
,1. Pharmacoeconomics is best defined as:
A. The study of how drugs are priced by pharmaceutical companies
B. The analysis of the costs and consequences of any health-care-related treatment or service
C. The comparison of generic versus brand-name drug pricing
D. The calculation of insurance premiums for prescription coverage
CORRECT ANSWER:
B. The analysis of the costs and consequences of any health-care-related treatment or service
RATIONALE:
Pharmacoeconomics systematically analyzes the costs (direct, indirect, intangible) and consequences
(outcomes) of healthcare treatments. It helps decision-makers allocate limited healthcare resources efficiently.
Options A, C, and D describe narrow aspects of drug pricing but do not capture the full scope of
pharmacoeconomic analysis, which encompasses all health-care-related treatments and services.
2. The direct costs of drug therapy include:
A. Pain and suffering due to inadequate drug therapy
B. Loss of wages while undergoing drug therapy
C. The actual cost of the medication and related medical services
D. Travel expenses to obtain the medication
CORRECT ANSWER:
A. Pain and suffering due to inadequate drug therapy
RATIONALE:
According to the source material, direct costs of drug therapy include pain and suffering due to inadequate drug
therapy. These are costs directly associated with the treatment or its failure. Loss of wages (B) is an indirect cost.
The actual medication cost (C) is another direct cost, but the source specifically identifies pain and suffering
from inadequate therapy as a direct cost.
, 3. Indirect costs associated with drug therapy include:
A. Loss of wages while undergoing drug therapy
B. The cost of the medication itself
C. The cost of physician visits for monitoring
D. Hospitalization costs related to drug therapy
CORRECT ANSWER:
A. Loss of wages while undergoing drug therapy
RATIONALE:
Indirect costs represent productivity losses — income lost when a patient cannot work due to illness or
treatment. Loss of wages while undergoing drug therapy is a classic indirect cost. Options B, C, and D are direct
medical costs (actual healthcare expenditures). Understanding these distinctions is essential for comprehensive
pharmacoeconomic analysis.
4. The intangible costs of drug therapy include:
A. Hospitalization expenses
B. Inconvenience, pain, and suffering incurred with therapy
C. Laboratory monitoring costs
D. Lost productivity at work
CORRECT ANSWER:
B. Inconvenience, pain, and suffering incurred with therapy
RATIONALE:
Intangible costs are non-monetary, quality-of-life impacts — inconvenience, pain, suffering, anxiety, and
reduced quality of life associated with illness or treatment. They are difficult to quantify but critically important
in pharmacoeconomic analysis. Option A and C are direct costs. Option D is an indirect cost.
